Funded by a $230,979 grant, an Ohio University study tests metformin to prevent Clostridioides difficile in heart patients.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted ...
A critical problem in treating Clostridioides difficile infections is the possibility that the pathogen develops resistance ...
High-dose cohort confirms the favorable safety profile and the dose-dependent immune response against Clostridioides ...
1d
Poop transplant to treat severe bacterial infection, bowel diseases; 400 procedures conducted so far
Most of us have heard of heart, liver and kidney transplants. But not many know about poop transplant or Faecal microbiota ...
A critical problem with treating Clostridioides difficile infections is the possibility that the pathogen develops resistance ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand ...
Kills C. difficile spores in 4 minutes1 and other pathogens, including C. auris and coronavirus, in 1 minute or less.
There was a significant decline in deaths from clostridioides difficile infections (CDI) among American individuals aged 35 years and above between 2011 and 2020, according to a May study published in ...
In a phase-one human clinical trial, a pharmacist researcher has demonstrated that a new antibiotic, called Omadacycline, may be a promising tool in combating the superbug known as C diff which causes ...
In addition to fighting off infections, several common antibiotics activate receptors in the gut. For example, azithromycin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results